Inhibrx Biosciences, Inc. (INBX) on GreekSoup https://greeksoup.ai/stocks/us/inbx/ Every dated entry in the public record on Inhibrx Biosciences, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Inhibrx Biosciences, Inc.: Schedule 13G/A filed by BANK OF AMERICA CORP /DE/, 2.4% of the classhttps://greeksoup.ai/stocks/us/inbx/holders/us:INBX:schedule-13:2026-10-28:7ba8853551Wed, 28 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: short interest 3,417,073 shares at the 15 October 2026 settlement, 16.83 days to coverhttps://greeksoup.ai/stocks/us/inbx/short-interest/us:INBX:short-interest:2026-10-15:99078ad753Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 2,470 shares at $84.07 on 14 October 2026, $207,655https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-10-14:806355e433Wed, 14 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 2,470 shares at $85.00 on 14 October 2026, $209,948https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-10-14:bdb1ad6ca2Wed, 14 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 100 shares at $85.76 on 14 October 2026, $8,576https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-10-14:ab8ae276cbWed, 14 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by Lappe Descendants' Trust, bought 2,449 shares at $84.07 on 14 October 2026, $205,889https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-10-14:a4ee56b706Wed, 14 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by Lappe Descendants' Trust, bought 2,451 shares at $85.00 on 14 October 2026, $208,333https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-10-14:0e09f544cbWed, 14 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by Lappe Descendants' Trust, bought 100 shares at $85.76 on 14 October 2026, $8,576https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-10-14:106f258f78Wed, 14 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: short interest 3,432,642 shares at the 30 September 2026 settlement, 11.82 days to coverhttps://greeksoup.ai/stocks/us/inbx/short-interest/us:INBX:short-interest:2026-09-30:6c0fd272b9Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/inbx/filings/us:INBX:filing:2026-09-28:bb2428dc08Mon, 28 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 1,500 shares at $98.88 on 28 September 2026, $148,320https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-28:60047c19a2Mon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 3,000 shares at $101.70 on 28 September 2026, $305,106https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-28:6b8f796a2cMon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 3,324 shares at $98.87 on 25 September 2026, $328,630https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-28:d41c2b435aMon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 2,176 shares at $99.60 on 25 September 2026, $216,727https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-28:d6eb010e38Mon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Kayyem Jon Faiz (Director), by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust, bought 5,000 shares at $100.00 on 23 September 2026, $500,000https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-23:8d79401587Wed, 23 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Kayyem Jon Faiz (Director), by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust, bought 5,000 shares at $100.00 on 16 September 2026, $500,000https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-17:d6d9d630d5Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Form 144, MANHARD KIMBERLY plans to sell 500 shares worth $52,525 around 15 September 2026https://greeksoup.ai/stocks/us/inbx/planned-sales/us:INBX:planned-sale:2026-09-15:b605aa216dTue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Manhard Kimberly (Director), kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012, sold 500 shares at $105.05 on 15 September 2026, $52,525https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-15:d207ac311cTue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Manhard Kimberly (Director), kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012, sold 500 shares at $110.26 on 14 September 2026, $55,130https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-15:a5ef20cf03Tue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Manhard Kimberly (Director), kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012, sold 500 shares at $111.78 on 11 September 2026, $55,888https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-15:22a366ed31Tue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: short interest 3,393,511 shares at the 15 September 2026 settlement, 8.31 days to coverhttps://greeksoup.ai/stocks/us/inbx/short-interest/us:INBX:short-interest:2026-09-15:ea2dbcae06Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Form 144, MANHARD KIMBERLY plans to sell 500 shares worth $55,130 around 14 September 2026https://greeksoup.ai/stocks/us/inbx/planned-sales/us:INBX:planned-sale:2026-09-14:772739b856Mon, 14 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Form 144, MANHARD KIMBERLY plans to sell 500 shares worth $55,888 around 11 September 2026https://greeksoup.ai/stocks/us/inbx/planned-sales/us:INBX:planned-sale:2026-09-11:d56b03aad6Fri, 11 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Manhard Kimberly (Director), kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012, sold 500 shares at $115.80 on 9 September 2026, $57,898https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-10:a030e9254bThu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Manhard Kimberly (Director), kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012, sold 500 shares at $115.14 on 8 September 2026, $57,570https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-10:5bc6551aacThu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Form 144, MANHARD KIMBERLY plans to sell 500 shares worth $57,898 around 9 September 2026https://greeksoup.ai/stocks/us/inbx/planned-sales/us:INBX:planned-sale:2026-09-09:851c098ae5Wed, 09 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/inbx/filings/us:INBX:filing:2026-09-08:fc802a4ba6Tue, 08 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Form 144, MANHARD KIMBERLY plans to sell 500 shares worth $57,570 around 8 September 2026https://greeksoup.ai/stocks/us/inbx/planned-sales/us:INBX:planned-sale:2026-09-08:993da0e081Tue, 08 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Kayyem Jon Faiz (Director), by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust, bought 5,000 shares at $113.52 on 8 September 2026, $567,580https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-08:89713e577cTue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Forsyth Douglas (Director), by the Forsyth Family Trust Dated July 20, 2001, bought 2,500 shares at $114.65 on 8 September 2026, $286,617https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-08:79bcbe0f31Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 5,895 shares at $99.29 on 8 September 2026, $585,343https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-08:ab01994a03Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 6,605 shares at $100.64 on 8 September 2026, $664,719https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-08:b06a7769b1Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 1,100 shares at $107.12 on 8 September 2026, $117,836https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-08:33ffd200dfTue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 500 shares at $108.23 on 8 September 2026, $54,118https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-08:e47d0c3b0fTue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 1,219 shares at $111.88 on 8 September 2026, $136,382https://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-08:f4c44c70e9Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Lappe Mark (Chief Executive Officer), by the Lappe Family Trust, bought 9,681 shares at $112.28 on 8 September 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/inbx/insiders/us:INBX:insider:2026-09-08:e5ecc3a19dTue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: short interest 3,297,743 shares at the 31 August 2026 settlement, 10.39 days to coverhttps://greeksoup.ai/stocks/us/inbx/short-interest/us:INBX:short-interest:2026-08-31:0bf369870fMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Schedule 13G filed by Schonfeld Strategic Advisors LLC, 5.3% of the classhttps://greeksoup.ai/stocks/us/inbx/holders/us:INBX:schedule-13:2026-08-14:4ea2706492Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Schedule 13G/A filed by Perceptive Advisors LLC, 10.0% of the classhttps://greeksoup.ai/stocks/us/inbx/holders/us:INBX:schedule-13:2026-08-14:c6e6646bb8Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Schedule 13G/A filed by VIKING GLOBAL INVESTORS LP, 9.3% of the classhttps://greeksoup.ai/stocks/us/inbx/holders/us:INBX:schedule-13:2026-08-14:e05a88262cFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: short interest 3,215,230 shares at the 14 August 2026 settlement, 14.39 days to coverhttps://greeksoup.ai/stocks/us/inbx/short-interest/us:INBX:short-interest:2026-08-14:d811335a14Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc. Q2 FY2026 results: revenue $0, net income -$37 millionhttps://greeksoup.ai/stocks/us/inbx/results/fy2026-q2/us:INBX:result:2026-08-13:722b7ee686Thu, 13 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/inbx/filings/us:INBX:filing:2026-08-13:97d6477fe3Thu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/inbx/filings/us:INBX:filing:2026-08-13:4b141c6601Thu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Inhibrx Biosciences, Inc.: Schedule 13G filed by BANK OF AMERICA CORP /DE/, 5.9% of the classhttps://greeksoup.ai/stocks/us/inbx/holders/us:INBX:schedule-13:2026-08-03:5266f0fdb4Mon, 03 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]>